Anthem Biosciences Limited has informed the Exchange regarding 'Intimation of violation under Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons as required under SEBI (Prohibition of Insider Trading) Regulations 2015 ( SEBI PIT Regulations )'.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has informed the NSE about a violation of its internal Code of Conduct framed under SEBI's Prohibition of Insider Trading (PIT) Regulations, 2015. The violation was committed by a designated person covered under the company's insider trading policy. The company has reported this to the Exchange as mandated, but no specific details of the violation, the person involved, or any financial penalty have been disclosed in the filing. Such intimations are standard procedural disclosures required when a company identifies a breach by insiders such as employees, directors, or their immediate relatives.
This is a routine compliance disclosure rather than a regulatory action against the company itself. The actual impact on the stock is likely minimal unless the violation is material, involves large undisclosed trades, or escalates into a formal SEBI investigation or penalty. Investors should watch for follow-up filings clarifying the nature and quantum of the violation.